These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 35069683)
1. Comprehensive Analysis of Pyroptosis-Associated in Molecular Classification, Immunity and Prognostic of Glioma. Chen P; Li Y; Li N; Shen L; Li Z Front Genet; 2021; 12():781538. PubMed ID: 35069683 [TBL] [Abstract][Full Text] [Related]
2. Integrative analysis reveals the functional implications and clinical relevance of pyroptosis in low-grade glioma. Shen L; Li Y; Li N; Zhao Y; Zhou Q; Shen L; Li Z Sci Rep; 2022 Mar; 12(1):4527. PubMed ID: 35296768 [TBL] [Abstract][Full Text] [Related]
3. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma. Zhang Y; Zhang C; Yang Y; Wang G; Wang Z; Liu J; Zhang L; Yu Y Front Cell Dev Biol; 2022; 10():862493. PubMed ID: 35547808 [No Abstract] [Full Text] [Related]
4. Molecular Subtypes and Prognostic Signature of Pyroptosis-Related lncRNAs in Glioma Patients. Tanzhu G; Li N; Li Z; Zhou R; Shen L Front Oncol; 2022; 12():779168. PubMed ID: 35237509 [TBL] [Abstract][Full Text] [Related]
5. Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma. Zeng Y; Cai Y; Chai P; Mao Y; Chen Y; Wang L; Zeng K; Zhan Z; Xie Y; Li C; Zhan H; Zhao L; Chen X; Zhu X; Liu Y; Chen M; Song Y; Zhou A Front Immunol; 2022; 13():961933. PubMed ID: 35990696 [TBL] [Abstract][Full Text] [Related]
6. A Novel Risk Signature with Seven Pyroptosis-Related Genes for Prognosis Prediction in Glioma. Huang Q; Li J; Mo L; Zhao Y World Neurosurg; 2022 Mar; 159():e285-e302. PubMed ID: 34929369 [TBL] [Abstract][Full Text] [Related]
7. A Novel Defined Pyroptosis-Related Gene Signature for Predicting Prognosis and Treatment of Glioma. Yang Z; Chen Z; Wang Y; Wang Z; Zhang D; Yue X; Zheng Y; Li L; Bian E; Zhao B Front Oncol; 2022; 12():717926. PubMed ID: 35433410 [TBL] [Abstract][Full Text] [Related]
8. Predicting the prognosis of glioma by pyroptosis-related signature. Chao B; Jiang F; Bai H; Meng P; Wang L; Wang F J Cell Mol Med; 2022 Jan; 26(1):133-143. PubMed ID: 34816605 [TBL] [Abstract][Full Text] [Related]
9. Prognostic characterization of the pyroptosis-related subtypes and tumor microenvironment infiltration in glioma. He J; Zhou W; Zhang M Cancer Biomark; 2023; 37(3):161-177. PubMed ID: 37248887 [TBL] [Abstract][Full Text] [Related]
10. Identification of a novel pyroptosis-related gene signature correlated with the prognosis of diffuse glioma patients. Zhang Y; Xi F; Yu Q; Lou W; Zeng Z; Su N; Gao J; Duan S; Deng Y; Guo S; Lai S; Tang X; Zhang J Ann Transl Med; 2021 Dec; 9(24):1766. PubMed ID: 35071460 [TBL] [Abstract][Full Text] [Related]
11. Pyroptosis: a novel signature to predict prognosis and immunotherapy response in gliomas. He G; Chen Z; Zhuo S; Tang J; Hao W; Yang K; Yang C Hum Cell; 2022 Nov; 35(6):1976-1992. PubMed ID: 36129672 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of a pyroptosis-related genes signature for risk stratification in gliomas. Sun P; Wang X; Zhong J; Yu D; Xuan H; Xu T; Song D; Yang C; Wang P; Liu Y; Meng X; Cai J Front Genet; 2023; 14():1087563. PubMed ID: 36861130 [No Abstract] [Full Text] [Related]
13. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients. He Y; Ye Y; Tian W; Qiu H Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662 [No Abstract] [Full Text] [Related]
14. A Novel Prognostic Pyroptosis-Related Gene Signature Correlates to Oxidative Stress and Immune-Related Features in Gliomas. Zeng S; Li W; Ouyang H; Xie Y; Feng X; Huang L Oxid Med Cell Longev; 2023; 2023():4256116. PubMed ID: 36778205 [TBL] [Abstract][Full Text] [Related]
15. Construction and Verification of a Novel Pyroptosis-Related lncRNA Signature Associated with Immune Landscape in Gliomas. Feng X; Chen Y; Liu X; Zhong Z; Liu Y J Oncol; 2022; 2022():7043431. PubMed ID: 36281290 [TBL] [Abstract][Full Text] [Related]
16. Identification and Validation of a Gene Signature for Lower-Grade Gliomas Based on Pyroptosis-Related Genes to Predict Survival and Response to Immune Checkpoint Inhibitors. Lai G; Li K; Deng J; Liu H; Xie B; Zhong X J Healthc Eng; 2022; 2022():8704127. PubMed ID: 35535221 [TBL] [Abstract][Full Text] [Related]
17. Identification and verification of the pyroptosis-related prognostic signature and its associated regulatory axis in bladder cancer. Tu Y; Ding X; Mao Z Front Cell Dev Biol; 2022; 10():912008. PubMed ID: 36120583 [No Abstract] [Full Text] [Related]
18. Development of a Prognostic Model of Glioma Based on Pyroptosis-Related Genes. Niu X; Cheng R; Wang Y; Chen J; Wang C; Ji H World Neurosurg; 2022 Feb; 158():e929-e945. PubMed ID: 34861452 [TBL] [Abstract][Full Text] [Related]
19. A Pyroptosis-Related Gene Signature Associated with Prognosis and Tumor Immune Microenvironment in Gliomas. Zhou Z; Xu J; Huang N; Tang J; Ma P; Cheng Y Int J Gen Med; 2022; 15():4753-4769. PubMed ID: 35571289 [TBL] [Abstract][Full Text] [Related]
20. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma. Zhao J; Wang L; Wei B Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]